miércoles, 3 de noviembre de 2010

FDA's Safe Use Initiative Workshop - Regulations.gov


FDA's Safe Use Initiative Workshop

Today, tens of millions of people in the United States depend on prescription and over-the-counter medications to sustain their health—as many as 3 billion prescriptions are written annually. Too many people, however, suffer unnecessary injuries, and some die as a result of preventable medication errors. The Food and Drug Administration's (FDA's) Safe Use Initiative aims to reduce preventable harm by identifying specific, preventable medication risks and developing, implementing, and evaluating cross-sector interventions with partners who are committed to safe medication use.

In support of this initiative, FDA invites you to participate in a 1½-day public workshop to be held November 16 and 17, 2010. This public workshop, organized and hosted by FDA's Safe Use Initiative Team, will communicate the status of ongoing activities and future vision for Safe Use Initiative projects. The team will gather input and perspectives for future directions toward the development of collaborative, cross-sector safe medication use activities with health care stakeholders.

Day 1: November 16, 2010 | 8:30 a.m. to 4:45 p.m. Eastern Time
Day 2: November 17, 2010 | 8:30 a.m. to 12 p.m. Eastern Time

FDA's White Oak Campus
10903 New Hampshire Avenue, Building 31, Room 1503
Silver Spring, MD 20993-0002

FDA is soliciting in advance of the public workshop topics for potential Safe Use collaborations. FDA will consider all topics; however, if submitted by November 10, 2010, some topics may become the focus for more in-depth discussions and partnership development during the public workshop. When submitting a topic for consideration, please suggest how it could become a Safe Use project (e.g., other health care partners who might have an interest in the issue, kinds of interventions to reduce preventable harm, and metrics). Submit electronic comments to http://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852.
Regulations.gov

No hay comentarios: